Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

NCT02317783 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Enrollment challenges

Conditions

Breast Cancer

Interventions

DRUG: [18F]Flutemetamol
DRUG: [18F]fluoro-2-deoxy-D-glucose (FDG)
DIAGNOSTIC_TEST: Functional Magnetic Resonance Imaging (fMRI)

Sponsor

University of Utah